サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
市場調査レポート
商品コード
1762884

医薬品業界におけるCMOの世界市場 2025～2029年

Global CMO Market in Pharmaceutical Industry 2025-2029

出版日
発行
TechNavio
ページ情報
英文 208 Pages
納期
即納可能 即納可能とは
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=148.47円
医薬品業界におけるCMOの世界市場 2025～2029年
出版日: 2025年06月28日
発行: TechNavio
ページ情報: 英文 208 Pages
納期: 即納可能 即納可能とは
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

医薬品業界におけるCMO市場は2024～2029年に4,270万米ドル、予測期間中のCAGRは6.5%で成長すると予測されます。

当レポートでは、医薬品業界におけるCMO市場の全体的な分析、市場規模・予測、動向、成長促進要因、25社前後のベンダー分析などを掲載しています。

現在の市場シナリオ、最新動向と促進要因、市場環境全体に関する最新分析を提供しています。市場は、新興市場におけるコスト効率の高いリソースの利用可能性、コアコンピテンシーに集中するニーズの高まり、強力な研究資金によって牽引されています。

市場範囲
基準年 2025年
終了年 2029年
予測期間 2025～2029年
成長モメンタム 加速
前年比 6%
CAGR 6.5%
増分額 4,270万米ドル

本調査は、業界の主要参加者からのインプットを含め、一次情報と二次情報を客観的に組み合わせて実施しました。レポートには、主要企業の分析に加え、包括的な市場規模データ、地域分析によるセグメント、ベンダー情勢が含まれています。レポートには過去データと予測データがあります。

本調査では、米国FDA認可の製造施設が、今後数年間の医薬品業界におけるCMO市場の成長を促進する主要な理由の1つであると特定しています。また、新規製造のための契約数の増加やビッグデータの出現は、市場の大規模な需要につながります。

目次

第1章 エグゼクティブサマリー

  • 市場概要

第2章 Technavio分析

  • 価格・ライフサイクル・顧客購入バスケット・採用率・購入基準の分析
  • インプットの重要性と差別化の要因
  • 混乱の要因
  • 促進要因と課題の影響

第3章 市場情勢

  • 市場エコシステム
  • 市場の特徴
  • バリューチェーン分析

第4章 市場規模

  • 市場の定義
  • 市場セグメント分析
  • 市場規模 2024年
  • 市場の見通し 2024～2029年

第5章 市場規模実績

  • 医薬品業界におけるCMOの世界市場 2019～2023年
  • サービス別セグメント分析 2019～2023年
  • 薬物クラス別セグメント分析 2019～2023年
  • エンドユーザー別セグメント分析 2019～2023年
  • 地域別セグメント分析 2019～2023年
  • 国別セグメント分析 2019～2023年

第6章 定性分析

  • AIの影響：医薬品業界におけるCMOの世界市場

第7章 ファイブフォース分析

  • ファイブフォースの要約
  • 買い手の交渉力
  • 供給企業の交渉力
  • 新規参入業者の脅威
  • 代替品の脅威
  • 競争の脅威
  • 市況

第8章 市場セグメンテーション：サービス別

  • 市場セグメント
  • 比較：サービス別
  • API製造：市場規模と予測 2024～2029年
  • FDF製造：市場規模と予測 2024～2029年
  • 市場機会：サービス別

第9章 市場セグメンテーション：薬剤クラス別

  • 市場セグメント
  • 比較：薬剤クラス別
  • 小分子：市場規模と予測 2024～2029年
  • 医薬品生物学的製剤：市場規模と予測 2024～2029年
  • 高効力薬：市場規模と予測 2024～2029年
  • 市場機会：薬剤クラス別

第10章 市場セグメンテーション：エンドユーザー別

  • 市場セグメント
  • 比較：エンドユーザー別
  • 大手製薬会社：市場規模と予測 2024～2029年
  • 中小企業：市場規模と予測 2024～2029年
  • ジェネリック医薬品メーカー：市場規模と予測 2024～2029年
  • バイオテクノロジー企業：市場規模と予測 2024～2029年
  • 市場機会：エンドユーザー別

第11章 顧客情勢

  • 顧客情勢の概要

第12章 地域別情勢

  • 地域別セグメンテーション
  • 地域別比較
  • 欧州：市場規模と予測 2024～2029年
  • 北米：市場規模と予測 2024～2029年
  • アジア太平洋：市場規模と予測 2024～2029年
  • 中東・アフリカ：市場規模と予測 2024～2029年
  • 南米：市場規模と予測 2024～2029年
  • 米国：市場規模と予測 2024～2029年
  • ドイツ：市場規模と予測 2024～2029年
  • 中国：市場規模と予測 2024～2029年
  • フランス：市場規模と予測 2024～2029年
  • カナダ：市場規模と予測 2024～2029年
  • 英国：市場規模と予測 2024～2029年
  • イタリア：市場規模と予測 2024～2029年
  • スペイン：市場規模と予測 2024～2029年
  • 日本：市場規模と予測 2024～2029年
  • インド：市場規模と予測 2024～2029年
  • 市場機会：地域情勢別

第13章 促進要因・課題・機会・抑制要因

  • 市場促進要因
  • 市場の課題
  • 促進要因と課題の影響
  • 市場の機会・抑制要因

第14章 競合情勢

  • 概要
  • 競合情勢
  • 混乱の状況
  • 業界のリスク

第15章 競合分析

  • 企業プロファイル
  • 企業ランキング指数
  • 企業の市場ポジショニング
  • Almac Group Ltd.
  • Boehringer Ingelheim International GmbH
  • Cadila Pharmaceuticals Ltd.
  • Cambrex Corp.
  • Catalent Inc.
  • Cipla Inc.
  • Cmic Holdings Co. Ltd
  • Curia Global Inc.
  • Dr Reddys Laboratories Ltd.
  • FAMAR Health Care Services
  • Jubilant Pharma Ltd.
  • Lonza Group Ltd.
  • Lupin Ltd.
  • Pfizer Inc.
  • Thermo Fisher Scientific Inc.

第16章 付録

図表

Exhibits:

  • Exhibits1: Executive Summary - Chart on Market Overview
  • Exhibits2: Executive Summary - Data Table on Market Overview
  • Exhibits3: Executive Summary - Chart on Global Market Characteristics
  • Exhibits4: Executive Summary - Chart on Market By Geographical Landscape
  • Exhibits5: Executive Summary - Chart on Market Segmentation by Service
  • Exhibits6: Executive Summary - Chart on Market Segmentation by Drug Class
  • Exhibits7: Executive Summary - Chart on Market Segmentation by End-user
  • Exhibits8: Executive Summary - Chart on Incremental Growth
  • Exhibits9: Executive Summary - Data Table on Incremental Growth
  • Exhibits10: Executive Summary - Chart on Company Market Positioning
  • Exhibits11: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
  • Exhibits12: Overview on criticality of inputs and factors of differentiation
  • Exhibits13: Overview on factors of disruption
  • Exhibits14: Impact of drivers and challenges in 2024 and 2029
  • Exhibits15: Parent Market
  • Exhibits16: Data Table on - Parent Market
  • Exhibits17: Market characteristics analysis
  • Exhibits18: Value chain analysis
  • Exhibits19: Offerings of companies included in the market definition
  • Exhibits20: Market segments
  • Exhibits21: Chart on Global - Market size and forecast 2024-2029 ($ million)
  • Exhibits22: Data Table on Global - Market size and forecast 2024-2029 ($ million)
  • Exhibits23: Chart on Global Market: Year-over-year growth 2024-2029 (%)
  • Exhibits24: Data Table on Global Market: Year-over-year growth 2024-2029 (%)
  • Exhibits25: Historic Market Size - Data Table on Global CMO Market In Pharmaceutical Industry 2019 - 2023 ($ million)
  • Exhibits26: Historic Market Size - Service Segment 2019 - 2023 ($ million)
  • Exhibits27: Historic Market Size - Drug Class Segment 2019 - 2023 ($ million)
  • Exhibits28: Historic Market Size - End-user Segment 2019 - 2023 ($ million)
  • Exhibits29: Historic Market Size - Geography Segment 2019 - 2023 ($ million)
  • Exhibits30: Historic Market Size - Country Segment 2019 - 2023 ($ million)
  • Exhibits31: Five forces analysis - Comparison between 2024 and 2029
  • Exhibits32: Bargaining power of buyers - Impact of key factors 2024 and 2029
  • Exhibits33: Bargaining power of suppliers - Impact of key factors in 2024 and 2029
  • Exhibits34: Threat of new entrants - Impact of key factors in 2024 and 2029
  • Exhibits35: Threat of substitutes - Impact of key factors in 2024 and 2029
  • Exhibits36: Threat of rivalry - Impact of key factors in 2024 and 2029
  • Exhibits37: Chart on Market condition - Five forces 2024 and 2029
  • Exhibits38: Chart on Service - Market share 2024-2029 (%)
  • Exhibits39: Data Table on Service - Market share 2024-2029 (%)
  • Exhibits40: Chart on Comparison by Service
  • Exhibits41: Data Table on Comparison by Service
  • Exhibits42: Chart on API manufacturing - Market size and forecast 2024-2029 ($ million)
  • Exhibits43: Data Table on API manufacturing - Market size and forecast 2024-2029 ($ million)
  • Exhibits44: Chart on API manufacturing - Year-over-year growth 2024-2029 (%)
  • Exhibits45: Data Table on API manufacturing - Year-over-year growth 2024-2029 (%)
  • Exhibits46: Chart on FDF manufacturing - Market size and forecast 2024-2029 ($ million)
  • Exhibits47: Data Table on FDF manufacturing - Market size and forecast 2024-2029 ($ million)
  • Exhibits48: Chart on FDF manufacturing - Year-over-year growth 2024-2029 (%)
  • Exhibits49: Data Table on FDF manufacturing - Year-over-year growth 2024-2029 (%)
  • Exhibits50: Market opportunity by Service ($ million)
  • Exhibits51: Data Table on Market opportunity by Service ($ million)
  • Exhibits52: Chart on Drug Class - Market share 2024-2029 (%)
  • Exhibits53: Data Table on Drug Class - Market share 2024-2029 (%)
  • Exhibits54: Chart on Comparison by Drug Class
  • Exhibits55: Data Table on Comparison by Drug Class
  • Exhibits56: Chart on Small molecule - Market size and forecast 2024-2029 ($ million)
  • Exhibits57: Data Table on Small molecule - Market size and forecast 2024-2029 ($ million)
  • Exhibits58: Chart on Small molecule - Year-over-year growth 2024-2029 (%)
  • Exhibits59: Data Table on Small molecule - Year-over-year growth 2024-2029 (%)
  • Exhibits60: Chart on Drugs biologics - Market size and forecast 2024-2029 ($ million)
  • Exhibits61: Data Table on Drugs biologics - Market size and forecast 2024-2029 ($ million)
  • Exhibits62: Chart on Drugs biologics - Year-over-year growth 2024-2029 (%)
  • Exhibits63: Data Table on Drugs biologics - Year-over-year growth 2024-2029 (%)
  • Exhibits64: Chart on High potency drugs - Market size and forecast 2024-2029 ($ million)
  • Exhibits65: Data Table on High potency drugs - Market size and forecast 2024-2029 ($ million)
  • Exhibits66: Chart on High potency drugs - Year-over-year growth 2024-2029 (%)
  • Exhibits67: Data Table on High potency drugs - Year-over-year growth 2024-2029 (%)
  • Exhibits68: Market opportunity by Drug Class ($ million)
  • Exhibits69: Data Table on Market opportunity by Drug Class ($ million)
  • Exhibits70: Chart on End-user - Market share 2024-2029 (%)
  • Exhibits71: Data Table on End-user - Market share 2024-2029 (%)
  • Exhibits72: Chart on Comparison by End-user
  • Exhibits73: Data Table on Comparison by End-user
  • Exhibits74: Chart on Big pharma - Market size and forecast 2024-2029 ($ million)
  • Exhibits75: Data Table on Big pharma - Market size and forecast 2024-2029 ($ million)
  • Exhibits76: Chart on Big pharma - Year-over-year growth 2024-2029 (%)
  • Exhibits77: Data Table on Big pharma - Year-over-year growth 2024-2029 (%)
  • Exhibits78: Chart on Small and medium enterprises (SMEs) - Market size and forecast 2024-2029 ($ million)
  • Exhibits79: Data Table on Small and medium enterprises (SMEs) - Market size and forecast 2024-2029 ($ million)
  • Exhibits80: Chart on Small and medium enterprises (SMEs) - Year-over-year growth 2024-2029 (%)
  • Exhibits81: Data Table on Small and medium enterprises (SMEs) - Year-over-year growth 2024-2029 (%)
  • Exhibits82: Chart on Generic drug manufacturers - Market size and forecast 2024-2029 ($ million)
  • Exhibits83: Data Table on Generic drug manufacturers - Market size and forecast 2024-2029 ($ million)
  • Exhibits84: Chart on Generic drug manufacturers - Year-over-year growth 2024-2029 (%)
  • Exhibits85: Data Table on Generic drug manufacturers - Year-over-year growth 2024-2029 (%)
  • Exhibits86: Chart on Biotech companies - Market size and forecast 2024-2029 ($ million)
  • Exhibits87: Data Table on Biotech companies - Market size and forecast 2024-2029 ($ million)
  • Exhibits88: Chart on Biotech companies - Year-over-year growth 2024-2029 (%)
  • Exhibits89: Data Table on Biotech companies - Year-over-year growth 2024-2029 (%)
  • Exhibits90: Market opportunity by End-user ($ million)
  • Exhibits91: Data Table on Market opportunity by End-user ($ million)
  • Exhibits92: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
  • Exhibits93: Chart on Market share By Geographical Landscape 2024-2029 (%)
  • Exhibits94: Data Table on Market share By Geographical Landscape 2024-2029 (%)
  • Exhibits95: Chart on Geographic comparison
  • Exhibits96: Data Table on Geographic comparison
  • Exhibits97: Chart on Europe - Market size and forecast 2024-2029 ($ million)
  • Exhibits98: Data Table on Europe - Market size and forecast 2024-2029 ($ million)
  • Exhibits99: Chart on Europe - Year-over-year growth 2024-2029 (%)
  • Exhibits100: Data Table on Europe - Year-over-year growth 2024-2029 (%)
  • Exhibits101: Chart on North America - Market size and forecast 2024-2029 ($ million)
  • Exhibits102: Data Table on North America - Market size and forecast 2024-2029 ($ million)
  • Exhibits103: Chart on North America - Year-over-year growth 2024-2029 (%)
  • Exhibits104: Data Table on North America - Year-over-year growth 2024-2029 (%)
  • Exhibits105: Chart on APAC - Market size and forecast 2024-2029 ($ million)
  • Exhibits106: Data Table on APAC - Market size and forecast 2024-2029 ($ million)
  • Exhibits107: Chart on APAC - Year-over-year growth 2024-2029 (%)
  • Exhibits108: Data Table on APAC - Year-over-year growth 2024-2029 (%)
  • Exhibits109: Chart on Middle East and Africa - Market size and forecast 2024-2029 ($ million)
  • Exhibits110: Data Table on Middle East and Africa - Market size and forecast 2024-2029 ($ million)
  • Exhibits111: Chart on Middle East and Africa - Year-over-year growth 2024-2029 (%)
  • Exhibits112: Data Table on Middle East and Africa - Year-over-year growth 2024-2029 (%)
  • Exhibits113: Chart on South America - Market size and forecast 2024-2029 ($ million)
  • Exhibits114: Data Table on South America - Market size and forecast 2024-2029 ($ million)
  • Exhibits115: Chart on South America - Year-over-year growth 2024-2029 (%)
  • Exhibits116: Data Table on South America - Year-over-year growth 2024-2029 (%)
  • Exhibits117: Chart on US - Market size and forecast 2024-2029 ($ million)
  • Exhibits118: Data Table on US - Market size and forecast 2024-2029 ($ million)
  • Exhibits119: Chart on US - Year-over-year growth 2024-2029 (%)
  • Exhibits120: Data Table on US - Year-over-year growth 2024-2029 (%)
  • Exhibits121: Chart on Germany - Market size and forecast 2024-2029 ($ million)
  • Exhibits122: Data Table on Germany - Market size and forecast 2024-2029 ($ million)
  • Exhibits123: Chart on Germany - Year-over-year growth 2024-2029 (%)
  • Exhibits124: Data Table on Germany - Year-over-year growth 2024-2029 (%)
  • Exhibits125: Chart on China - Market size and forecast 2024-2029 ($ million)
  • Exhibits126: Data Table on China - Market size and forecast 2024-2029 ($ million)
  • Exhibits127: Chart on China - Year-over-year growth 2024-2029 (%)
  • Exhibits128: Data Table on China - Year-over-year growth 2024-2029 (%)
  • Exhibits129: Chart on France - Market size and forecast 2024-2029 ($ million)
  • Exhibits130: Data Table on France - Market size and forecast 2024-2029 ($ million)
  • Exhibits131: Chart on France - Year-over-year growth 2024-2029 (%)
  • Exhibits132: Data Table on France - Year-over-year growth 2024-2029 (%)
  • Exhibits133: Chart on Canada - Market size and forecast 2024-2029 ($ million)
  • Exhibits134: Data Table on Canada - Market size and forecast 2024-2029 ($ million)
  • Exhibits135: Chart on Canada - Year-over-year growth 2024-2029 (%)
  • Exhibits136: Data Table on Canada - Year-over-year growth 2024-2029 (%)
  • Exhibits137: Chart on UK - Market size and forecast 2024-2029 ($ million)
  • Exhibits138: Data Table on UK - Market size and forecast 2024-2029 ($ million)
  • Exhibits139: Chart on UK - Year-over-year growth 2024-2029 (%)
  • Exhibits140: Data Table on UK - Year-over-year growth 2024-2029 (%)
  • Exhibits141: Chart on Italy - Market size and forecast 2024-2029 ($ million)
  • Exhibits142: Data Table on Italy - Market size and forecast 2024-2029 ($ million)
  • Exhibits143: Chart on Italy - Year-over-year growth 2024-2029 (%)
  • Exhibits144: Data Table on Italy - Year-over-year growth 2024-2029 (%)
  • Exhibits145: Chart on Spain - Market size and forecast 2024-2029 ($ million)
  • Exhibits146: Data Table on Spain - Market size and forecast 2024-2029 ($ million)
  • Exhibits147: Chart on Spain - Year-over-year growth 2024-2029 (%)
  • Exhibits148: Data Table on Spain - Year-over-year growth 2024-2029 (%)
  • Exhibits149: Chart on Japan - Market size and forecast 2024-2029 ($ million)
  • Exhibits150: Data Table on Japan - Market size and forecast 2024-2029 ($ million)
  • Exhibits151: Chart on Japan - Year-over-year growth 2024-2029 (%)
  • Exhibits152: Data Table on Japan - Year-over-year growth 2024-2029 (%)
  • Exhibits153: Chart on India - Market size and forecast 2024-2029 ($ million)
  • Exhibits154: Data Table on India - Market size and forecast 2024-2029 ($ million)
  • Exhibits155: Chart on India - Year-over-year growth 2024-2029 (%)
  • Exhibits156: Data Table on India - Year-over-year growth 2024-2029 (%)
  • Exhibits157: Market opportunity By Geographical Landscape ($ million)
  • Exhibits158: Data Tables on Market opportunity By Geographical Landscape ($ million)
  • Exhibits159: Impact of drivers and challenges in 2024 and 2029
  • Exhibits160: Overview on criticality of inputs and factors of differentiation
  • Exhibits161: Overview on factors of disruption
  • Exhibits162: Impact of key risks on business
  • Exhibits163: Companies covered
  • Exhibits164: Company ranking index
  • Exhibits165: Matrix on companies position and classification
  • Exhibits166: Almac Group Ltd. - Overview
  • Exhibits167: Almac Group Ltd. - Product / Service
  • Exhibits168: Almac Group Ltd. - Key offerings
  • Exhibits169: SWOT
  • Exhibits170: Boehringer Ingelheim International GmbH - Overview
  • Exhibits171: Boehringer Ingelheim International GmbH - Product / Service
  • Exhibits172: Boehringer Ingelheim International GmbH - Key news
  • Exhibits173: Boehringer Ingelheim International GmbH - Key offerings
  • Exhibits174: SWOT
  • Exhibits175: Cadila Pharmaceuticals Ltd. - Overview
  • Exhibits176: Cadila Pharmaceuticals Ltd. - Product / Service
  • Exhibits177: Cadila Pharmaceuticals Ltd. - Key offerings
  • Exhibits178: SWOT
  • Exhibits179: Cambrex Corp. - Overview
  • Exhibits180: Cambrex Corp. - Product / Service
  • Exhibits181: Cambrex Corp. - Key news
  • Exhibits182: Cambrex Corp. - Key offerings
  • Exhibits183: SWOT
  • Exhibits184: Catalent Inc. - Overview
  • Exhibits185: Catalent Inc. - Business segments
  • Exhibits186: Catalent Inc. - Key offerings
  • Exhibits187: Catalent Inc. - Segment focus
  • Exhibits188: SWOT
  • Exhibits189: Cipla Inc. - Overview
  • Exhibits190: Cipla Inc. - Business segments
  • Exhibits191: Cipla Inc. - Key news
  • Exhibits192: Cipla Inc. - Key offerings
  • Exhibits193: Cipla Inc. - Segment focus
  • Exhibits194: SWOT
  • Exhibits195: Cmic Holdings Co. Ltd - Overview
  • Exhibits196: Cmic Holdings Co. Ltd - Business segments
  • Exhibits197: Cmic Holdings Co. Ltd - Key offerings
  • Exhibits198: Cmic Holdings Co. Ltd - Segment focus
  • Exhibits199: SWOT
  • Exhibits200: Curia Global Inc. - Overview
  • Exhibits201: Curia Global Inc. - Product / Service
  • Exhibits202: Curia Global Inc. - Key offerings
  • Exhibits203: SWOT
  • Exhibits204: Dr Reddys Laboratories Ltd. - Overview
  • Exhibits205: Dr Reddys Laboratories Ltd. - Business segments
  • Exhibits206: Dr Reddys Laboratories Ltd. - Key news
  • Exhibits207: Dr Reddys Laboratories Ltd. - Key offerings
  • Exhibits208: Dr Reddys Laboratories Ltd. - Segment focus
  • Exhibits209: SWOT
  • Exhibits210: FAMAR Health Care Services - Overview
  • Exhibits211: FAMAR Health Care Services - Product / Service
  • Exhibits212: FAMAR Health Care Services - Key offerings
  • Exhibits213: SWOT
  • Exhibits214: Jubilant Pharma Ltd. - Overview
  • Exhibits215: Jubilant Pharma Ltd. - Product / Service
  • Exhibits216: Jubilant Pharma Ltd. - Key offerings
  • Exhibits217: SWOT
  • Exhibits218: Lonza Group Ltd. - Overview
  • Exhibits219: Lonza Group Ltd. - Business segments
  • Exhibits220: Lonza Group Ltd. - Key news
  • Exhibits221: Lonza Group Ltd. - Key offerings
  • Exhibits222: Lonza Group Ltd. - Segment focus
  • Exhibits223: SWOT
  • Exhibits224: Lupin Ltd. - Overview
  • Exhibits225: Lupin Ltd. - Business segments
  • Exhibits226: Lupin Ltd. - Key news
  • Exhibits227: Lupin Ltd. - Key offerings
  • Exhibits228: Lupin Ltd. - Segment focus
  • Exhibits229: SWOT
  • Exhibits230: Pfizer Inc. - Overview
  • Exhibits231: Pfizer Inc. - Product / Service
  • Exhibits232: Pfizer Inc. - Key news
  • Exhibits233: Pfizer Inc. - Key offerings
  • Exhibits234: SWOT
  • Exhibits235: Thermo Fisher Scientific Inc. - Overview
  • Exhibits236: Thermo Fisher Scientific Inc. - Business segments
  • Exhibits237: Thermo Fisher Scientific Inc. - Key news
  • Exhibits238: Thermo Fisher Scientific Inc. - Key offerings
  • Exhibits239: Thermo Fisher Scientific Inc. - Segment focus
  • Exhibits240: SWOT
  • Exhibits241: Inclusions checklist
  • Exhibits242: Exclusions checklist
  • Exhibits243: Currency conversion rates for US$
  • Exhibits244: Research methodology
  • Exhibits245: Information sources
  • Exhibits246: Data validation
  • Exhibits247: Validation techniques employed for market sizing
  • Exhibits248: Data synthesis
  • Exhibits249: 360 degree market analysis
  • Exhibits250: List of abbreviations
目次
Product Code: IRTNTR71566

The cmo in pharmaceutical industry market is forecasted to grow by USD 42.7 mn during 2024-2029, accelerating at a CAGR of 6.5% during the forecast period. The report on the cmo in pharmaceutical industry market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by availability of cost-efficient resources in emerging markets, growing need to focus on core competencies, and strong research funding.

Market Scope
Base Year2025
End Year2029
Series Year2025-2029
Growth MomentumAccelerate
YOY 20256%
CAGR6.5%
Incremental Value$42.7 mn

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market size data, segment with regional analysis and vendor landscape in addition to an analysis of the key companies. Reports have historic and forecast data.

Technavio's cmo in pharmaceutical industry market is segmented as below:

By Service

    • API manufacturing
    • FDF manufacturing

By Drug Class

    • Small molecule
    • Drugs biologics
    • High potency drugs

By End-user

    • Big pharma
    • Small and medium enterprises (SMEs)
    • Generic drug manufacturers
    • Biotech companies

By Geographical Landscape

    • Europe
    • North America
    • APAC
    • Middle East and Africa
    • South America

This study identifies the us fda-approved manufacturing facilities as one of the prime reasons driving the cmo in pharmaceutical industry market growth during the next few years. Also, increasing number of contracts for manufacturing novel and advent of big data will lead to sizable demand in the market.

The report on the cmo in pharmaceutical industry market covers the following areas:

    • CMO In Pharmaceutical Industry Market sizing
    • CMO In Pharmaceutical Industry Market forecast
    • CMO In Pharmaceutical Industry Market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading cmo in pharmaceutical industry market vendors that include Almac Group Ltd., Boehringer Ingelheim International GmbH, Cadila Pharmaceuticals Ltd., Cambrex Corp., Catalent Inc., Chongqing Huapont Pharmaceutical Co. Ltd., Cipla Inc., Cmic Holdings Co. Ltd, Curia Global Inc., Dr Reddys Laboratories Ltd., FAMAR Health Care Services, Jubilant Pharma Ltd., Lonza Group Ltd., Lupin Ltd., PCI Pharma Services, Pfizer Inc., Recipharm AB, Samsung Biologics Co. Ltd., Thermo Fisher Scientific Inc., and Vetter Pharma Fertigung GmbH and Co. KG. Also, the cmo in pharmaceutical industry market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.

Table of Contents

1 Executive Summary

  • 1.1 Market overview
    • Executive Summary - Chart on Market Overview
    • Executive Summary - Data Table on Market Overview
    • Executive Summary - Chart on Global Market Characteristics
    • Executive Summary - Chart on Market By Geographical Landscape
    • Executive Summary - Chart on Market Segmentation by Service
    • Executive Summary - Chart on Market Segmentation by Drug Class
    • Executive Summary - Chart on Market Segmentation by End-user
    • Executive Summary - Chart on Incremental Growth
    • Executive Summary - Data Table on Incremental Growth
    • Executive Summary - Chart on Company Market Positioning

2 Technavio Analysis

  • 2.1 Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
    • Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
  • 2.2 Criticality of inputs and Factors of differentiation
    • Overview on criticality of inputs and factors of differentiation
  • 2.3 Factors of disruption
    • Overview on factors of disruption
  • 2.4 Impact of drivers and challenges
    • Impact of drivers and challenges in 2024 and 2029

3 Market Landscape

  • 3.1 Market ecosystem
    • Parent Market
    • Data Table on - Parent Market
  • 3.2 Market characteristics
    • Market characteristics analysis
  • 3.3 Value chain analysis
    • Value chain analysis

4 Market Sizing

  • 4.1 Market definition
    • Offerings of companies included in the market definition
  • 4.2 Market segment analysis
    • Market segments
  • 4.3 Market size 2024
  • 4.4 Market outlook: Forecast for 2024-2029
    • Chart on Global - Market size and forecast 2024-2029 ($ million)
    • Data Table on Global - Market size and forecast 2024-2029 ($ million)
    • Chart on Global Market: Year-over-year growth 2024-2029 (%)
    • Data Table on Global Market: Year-over-year growth 2024-2029 (%)

5 Historic Market Size

  • 5.1 Global CMO Market In Pharmaceutical Industry 2019 - 2023
    • Historic Market Size - Data Table on Global CMO Market In Pharmaceutical Industry 2019 - 2023 ($ million)
  • 5.2 Service segment analysis 2019 - 2023
    • Historic Market Size - Service Segment 2019 - 2023 ($ million)
  • 5.3 Drug Class segment analysis 2019 - 2023
    • Historic Market Size - Drug Class Segment 2019 - 2023 ($ million)
  • 5.4 End-user segment analysis 2019 - 2023
    • Historic Market Size - End-user Segment 2019 - 2023 ($ million)
  • 5.5 Geography segment analysis 2019 - 2023
    • Historic Market Size - Geography Segment 2019 - 2023 ($ million)
  • 5.6 Country segment analysis 2019 - 2023
    • Historic Market Size - Country Segment 2019 - 2023 ($ million)

6 Qualitative Analysis

  • 6.1 The AI impact on global CMO market in pharmaceutical industry

7 Five Forces Analysis

  • 7.1 Five forces summary
    • Five forces analysis - Comparison between 2024 and 2029
  • 7.2 Bargaining power of buyers
    • Bargaining power of buyers - Impact of key factors 2024 and 2029
  • 7.3 Bargaining power of suppliers
    • Bargaining power of suppliers - Impact of key factors in 2024 and 2029
  • 7.4 Threat of new entrants
    • Threat of new entrants - Impact of key factors in 2024 and 2029
  • 7.5 Threat of substitutes
    • Threat of substitutes - Impact of key factors in 2024 and 2029
  • 7.6 Threat of rivalry
    • Threat of rivalry - Impact of key factors in 2024 and 2029
  • 7.7 Market condition
    • Chart on Market condition - Five forces 2024 and 2029

8 Market Segmentation by Service

  • 8.1 Market segments
    • Chart on Service - Market share 2024-2029 (%)
    • Data Table on Service - Market share 2024-2029 (%)
  • 8.2 Comparison by Service
    • Chart on Comparison by Service
    • Data Table on Comparison by Service
  • 8.3 API manufacturing - Market size and forecast 2024-2029
    • Chart on API manufacturing - Market size and forecast 2024-2029 ($ million)
    • Data Table on API manufacturing - Market size and forecast 2024-2029 ($ million)
    • Chart on API manufacturing - Year-over-year growth 2024-2029 (%)
    • Data Table on API manufacturing - Year-over-year growth 2024-2029 (%)
  • 8.4 FDF manufacturing - Market size and forecast 2024-2029
    • Chart on FDF manufacturing - Market size and forecast 2024-2029 ($ million)
    • Data Table on FDF manufacturing - Market size and forecast 2024-2029 ($ million)
    • Chart on FDF manufacturing - Year-over-year growth 2024-2029 (%)
    • Data Table on FDF manufacturing - Year-over-year growth 2024-2029 (%)
  • 8.5 Market opportunity by Service
    • Market opportunity by Service ($ million)
    • Data Table on Market opportunity by Service ($ million)

9 Market Segmentation by Drug Class

  • 9.1 Market segments
    • Chart on Drug Class - Market share 2024-2029 (%)
    • Data Table on Drug Class - Market share 2024-2029 (%)
  • 9.2 Comparison by Drug Class
    • Chart on Comparison by Drug Class
    • Data Table on Comparison by Drug Class
  • 9.3 Small molecule - Market size and forecast 2024-2029
    • Chart on Small molecule - Market size and forecast 2024-2029 ($ million)
    • Data Table on Small molecule - Market size and forecast 2024-2029 ($ million)
    • Chart on Small molecule - Year-over-year growth 2024-2029 (%)
    • Data Table on Small molecule - Year-over-year growth 2024-2029 (%)
  • 9.4 Drugs biologics - Market size and forecast 2024-2029
    • Chart on Drugs biologics - Market size and forecast 2024-2029 ($ million)
    • Data Table on Drugs biologics - Market size and forecast 2024-2029 ($ million)
    • Chart on Drugs biologics - Year-over-year growth 2024-2029 (%)
    • Data Table on Drugs biologics - Year-over-year growth 2024-2029 (%)
  • 9.5 High potency drugs - Market size and forecast 2024-2029
    • Chart on High potency drugs - Market size and forecast 2024-2029 ($ million)
    • Data Table on High potency drugs - Market size and forecast 2024-2029 ($ million)
    • Chart on High potency drugs - Year-over-year growth 2024-2029 (%)
    • Data Table on High potency drugs - Year-over-year growth 2024-2029 (%)
  • 9.6 Market opportunity by Drug Class
    • Market opportunity by Drug Class ($ million)
    • Data Table on Market opportunity by Drug Class ($ million)

10 Market Segmentation by End-user

  • 10.1 Market segments
    • Chart on End-user - Market share 2024-2029 (%)
    • Data Table on End-user - Market share 2024-2029 (%)
  • 10.2 Comparison by End-user
    • Chart on Comparison by End-user
    • Data Table on Comparison by End-user
  • 10.3 Big pharma - Market size and forecast 2024-2029
    • Chart on Big pharma - Market size and forecast 2024-2029 ($ million)
    • Data Table on Big pharma - Market size and forecast 2024-2029 ($ million)
    • Chart on Big pharma - Year-over-year growth 2024-2029 (%)
    • Data Table on Big pharma - Year-over-year growth 2024-2029 (%)
  • 10.4 Small and medium enterprises (SMEs) - Market size and forecast 2024-2029
    • Chart on Small and medium enterprises (SMEs) - Market size and forecast 2024-2029 ($ million)
    • Data Table on Small and medium enterprises (SMEs) - Market size and forecast 2024-2029 ($ million)
    • Chart on Small and medium enterprises (SMEs) - Year-over-year growth 2024-2029 (%)
    • Data Table on Small and medium enterprises (SMEs) - Year-over-year growth 2024-2029 (%)
  • 10.5 Generic drug manufacturers - Market size and forecast 2024-2029
    • Chart on Generic drug manufacturers - Market size and forecast 2024-2029 ($ million)
    • Data Table on Generic drug manufacturers - Market size and forecast 2024-2029 ($ million)
    • Chart on Generic drug manufacturers - Year-over-year growth 2024-2029 (%)
    • Data Table on Generic drug manufacturers - Year-over-year growth 2024-2029 (%)
  • 10.6 Biotech companies - Market size and forecast 2024-2029
    • Chart on Biotech companies - Market size and forecast 2024-2029 ($ million)
    • Data Table on Biotech companies - Market size and forecast 2024-2029 ($ million)
    • Chart on Biotech companies - Year-over-year growth 2024-2029 (%)
    • Data Table on Biotech companies - Year-over-year growth 2024-2029 (%)
  • 10.7 Market opportunity by End-user
    • Market opportunity by End-user ($ million)
    • Data Table on Market opportunity by End-user ($ million)

11 Customer Landscape

  • 11.1 Customer landscape overview
    • Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

12 Geographic Landscape

  • 12.1 Geographic segmentation
    • Chart on Market share By Geographical Landscape 2024-2029 (%)
    • Data Table on Market share By Geographical Landscape 2024-2029 (%)
  • 12.2 Geographic comparison
    • Chart on Geographic comparison
    • Data Table on Geographic comparison
  • 12.3 Europe - Market size and forecast 2024-2029
    • Chart on Europe - Market size and forecast 2024-2029 ($ million)
    • Data Table on Europe - Market size and forecast 2024-2029 ($ million)
    • Chart on Europe - Year-over-year growth 2024-2029 (%)
    • Data Table on Europe - Year-over-year growth 2024-2029 (%)
  • 12.4 North America - Market size and forecast 2024-2029
    • Chart on North America - Market size and forecast 2024-2029 ($ million)
    • Data Table on North America - Market size and forecast 2024-2029 ($ million)
    • Chart on North America - Year-over-year growth 2024-2029 (%)
    • Data Table on North America - Year-over-year growth 2024-2029 (%)
  • 12.5 APAC - Market size and forecast 2024-2029
    • Chart on APAC - Market size and forecast 2024-2029 ($ million)
    • Data Table on APAC - Market size and forecast 2024-2029 ($ million)
    • Chart on APAC - Year-over-year growth 2024-2029 (%)
    • Data Table on APAC - Year-over-year growth 2024-2029 (%)
  • 12.6 Middle East and Africa - Market size and forecast 2024-2029
    • Chart on Middle East and Africa - Market size and forecast 2024-2029 ($ million)
    • Data Table on Middle East and Africa - Market size and forecast 2024-2029 ($ million)
    • Chart on Middle East and Africa - Year-over-year growth 2024-2029 (%)
    • Data Table on Middle East and Africa - Year-over-year growth 2024-2029 (%)
  • 12.7 South America - Market size and forecast 2024-2029
    • Chart on South America - Market size and forecast 2024-2029 ($ million)
    • Data Table on South America - Market size and forecast 2024-2029 ($ million)
    • Chart on South America - Year-over-year growth 2024-2029 (%)
    • Data Table on South America - Year-over-year growth 2024-2029 (%)
  • 12.8 US - Market size and forecast 2024-2029
    • Chart on US - Market size and forecast 2024-2029 ($ million)
    • Data Table on US - Market size and forecast 2024-2029 ($ million)
    • Chart on US - Year-over-year growth 2024-2029 (%)
    • Data Table on US - Year-over-year growth 2024-2029 (%)
  • 12.9 Germany - Market size and forecast 2024-2029
    • Chart on Germany - Market size and forecast 2024-2029 ($ million)
    • Data Table on Germany - Market size and forecast 2024-2029 ($ million)
    • Chart on Germany - Year-over-year growth 2024-2029 (%)
    • Data Table on Germany - Year-over-year growth 2024-2029 (%)
  • 12.10 China - Market size and forecast 2024-2029
    • Chart on China - Market size and forecast 2024-2029 ($ million)
    • Data Table on China - Market size and forecast 2024-2029 ($ million)
    • Chart on China - Year-over-year growth 2024-2029 (%)
    • Data Table on China - Year-over-year growth 2024-2029 (%)
  • 12.11 France - Market size and forecast 2024-2029
    • Chart on France - Market size and forecast 2024-2029 ($ million)
    • Data Table on France - Market size and forecast 2024-2029 ($ million)
    • Chart on France - Year-over-year growth 2024-2029 (%)
    • Data Table on France - Year-over-year growth 2024-2029 (%)
  • 12.12 Canada - Market size and forecast 2024-2029
    • Chart on Canada - Market size and forecast 2024-2029 ($ million)
    • Data Table on Canada - Market size and forecast 2024-2029 ($ million)
    • Chart on Canada - Year-over-year growth 2024-2029 (%)
    • Data Table on Canada - Year-over-year growth 2024-2029 (%)
  • 12.13 UK - Market size and forecast 2024-2029
    • Chart on UK - Market size and forecast 2024-2029 ($ million)
    • Data Table on UK - Market size and forecast 2024-2029 ($ million)
    • Chart on UK - Year-over-year growth 2024-2029 (%)
    • Data Table on UK - Year-over-year growth 2024-2029 (%)
  • 12.14 Italy - Market size and forecast 2024-2029
    • Chart on Italy - Market size and forecast 2024-2029 ($ million)
    • Data Table on Italy - Market size and forecast 2024-2029 ($ million)
    • Chart on Italy - Year-over-year growth 2024-2029 (%)
    • Data Table on Italy - Year-over-year growth 2024-2029 (%)
  • 12.15 Spain - Market size and forecast 2024-2029
    • Chart on Spain - Market size and forecast 2024-2029 ($ million)
    • Data Table on Spain - Market size and forecast 2024-2029 ($ million)
    • Chart on Spain - Year-over-year growth 2024-2029 (%)
    • Data Table on Spain - Year-over-year growth 2024-2029 (%)
  • 12.16 Japan - Market size and forecast 2024-2029
    • Chart on Japan - Market size and forecast 2024-2029 ($ million)
    • Data Table on Japan - Market size and forecast 2024-2029 ($ million)
    • Chart on Japan - Year-over-year growth 2024-2029 (%)
    • Data Table on Japan - Year-over-year growth 2024-2029 (%)
  • 12.17 India - Market size and forecast 2024-2029
    • Chart on India - Market size and forecast 2024-2029 ($ million)
    • Data Table on India - Market size and forecast 2024-2029 ($ million)
    • Chart on India - Year-over-year growth 2024-2029 (%)
    • Data Table on India - Year-over-year growth 2024-2029 (%)
  • 12.18 Market opportunity By Geographical Landscape
    • Market opportunity By Geographical Landscape ($ million)
    • Data Tables on Market opportunity By Geographical Landscape ($ million)

13 Drivers, Challenges, and Opportunity/Restraints

  • 13.1 Market drivers
  • 13.2 Market challenges
  • 13.3 Impact of drivers and challenges
    • Impact of drivers and challenges in 2024 and 2029
  • 13.4 Market opportunities/restraints

14 Competitive Landscape

  • 14.1 Overview
  • 14.2 Competitive Landscape
    • Overview on criticality of inputs and factors of differentiation
  • 14.3 Landscape disruption
    • Overview on factors of disruption
  • 14.4 Industry risks
    • Impact of key risks on business

15 Competitive Analysis

  • 15.1 Companies profiled
    • Companies covered
  • 15.2 Company ranking index
    • Company ranking index
  • 15.3 Market positioning of companies
    • Matrix on companies position and classification
  • 15.4 Almac Group Ltd.
    • Almac Group Ltd. - Overview
    • Almac Group Ltd. - Product / Service
    • Almac Group Ltd. - Key offerings
    • SWOT
  • 15.5 Boehringer Ingelheim International GmbH
    • Boehringer Ingelheim International GmbH - Overview
    • Boehringer Ingelheim International GmbH - Product / Service
    • Boehringer Ingelheim International GmbH - Key news
    • Boehringer Ingelheim International GmbH - Key offerings
    • SWOT
  • 15.6 Cadila Pharmaceuticals Ltd.
    • Cadila Pharmaceuticals Ltd. - Overview
    • Cadila Pharmaceuticals Ltd. - Product / Service
    • Cadila Pharmaceuticals Ltd. - Key offerings
    • SWOT
  • 15.7 Cambrex Corp.
    • Cambrex Corp. - Overview
    • Cambrex Corp. - Product / Service
    • Cambrex Corp. - Key news
    • Cambrex Corp. - Key offerings
    • SWOT
  • 15.8 Catalent Inc.
    • Catalent Inc. - Overview
    • Catalent Inc. - Business segments
    • Catalent Inc. - Key offerings
    • Catalent Inc. - Segment focus
    • SWOT
  • 15.9 Cipla Inc.
    • Cipla Inc. - Overview
    • Cipla Inc. - Business segments
    • Cipla Inc. - Key news
    • Cipla Inc. - Key offerings
    • Cipla Inc. - Segment focus
    • SWOT
  • 15.10 Cmic Holdings Co. Ltd
    • Cmic Holdings Co. Ltd - Overview
    • Cmic Holdings Co. Ltd - Business segments
    • Cmic Holdings Co. Ltd - Key offerings
    • Cmic Holdings Co. Ltd - Segment focus
    • SWOT
  • 15.11 Curia Global Inc.
    • Curia Global Inc. - Overview
    • Curia Global Inc. - Product / Service
    • Curia Global Inc. - Key offerings
    • SWOT
  • 15.12 Dr Reddys Laboratories Ltd.
    • Dr Reddys Laboratories Ltd. - Overview
    • Dr Reddys Laboratories Ltd. - Business segments
    • Dr Reddys Laboratories Ltd. - Key news
    • Dr Reddys Laboratories Ltd. - Key offerings
    • Dr Reddys Laboratories Ltd. - Segment focus
    • SWOT
  • 15.13 FAMAR Health Care Services
    • FAMAR Health Care Services - Overview
    • FAMAR Health Care Services - Product / Service
    • FAMAR Health Care Services - Key offerings
    • SWOT
  • 15.14 Jubilant Pharma Ltd.
    • Jubilant Pharma Ltd. - Overview
    • Jubilant Pharma Ltd. - Product / Service
    • Jubilant Pharma Ltd. - Key offerings
    • SWOT
  • 15.15 Lonza Group Ltd.
    • Lonza Group Ltd. - Overview
    • Lonza Group Ltd. - Business segments
    • Lonza Group Ltd. - Key news
    • Lonza Group Ltd. - Key offerings
    • Lonza Group Ltd. - Segment focus
    • SWOT
  • 15.16 Lupin Ltd.
    • Lupin Ltd. - Overview
    • Lupin Ltd. - Business segments
    • Lupin Ltd. - Key news
    • Lupin Ltd. - Key offerings
    • Lupin Ltd. - Segment focus
    • SWOT
  • 15.17 Pfizer Inc.
    • Pfizer Inc. - Overview
    • Pfizer Inc. - Product / Service
    • Pfizer Inc. - Key news
    • Pfizer Inc. - Key offerings
    • SWOT
  • 15.18 Thermo Fisher Scientific Inc.
    • Thermo Fisher Scientific Inc. - Overview
    • Thermo Fisher Scientific Inc. - Business segments
    • Thermo Fisher Scientific Inc. - Key news
    • Thermo Fisher Scientific Inc. - Key offerings
    • Thermo Fisher Scientific Inc. - Segment focus
    • SWOT

16 Appendix

  • 16.1 Scope of the report
  • 16.2 Inclusions and exclusions checklist
    • Inclusions checklist
    • Exclusions checklist
  • 16.3 Currency conversion rates for US$
    • Currency conversion rates for US$
  • 16.4 Research methodology
    • Research methodology
  • 16.5 Data procurement
    • Information sources
  • 16.6 Data validation
    • Data validation
  • 16.7 Validation techniques employed for market sizing
    • Validation techniques employed for market sizing
  • 16.8 Data synthesis
    • Data synthesis
  • 16.9 360 degree market analysis
    • 360 degree market analysis
  • 16.10 List of abbreviations
    • List of abbreviations